Reported results
- Net sales were $69.8 million, an increase of 6% compared to the prior year period.
- Gross profit was $19.7 million, or 28.2% of sales, compared to $14.3 million, or 21.7% of sales, in the prior year period.
- Net income was $4.6 million, compared to $3.09 million in the prior year period.
- Net income per diluted share was $0.39, compared to $0.28 in the prior year period.
- Adjusted net income per diluted share (non-GAAP) was $0.52, compared to $0.31 in the prior year period.
- Adjusted EBITDA (non-GAAP) was $10.3 million, with an Adjusted EBITDA margin (non-GAAP) of 14.8%.
Guidance
- Full year fiscal 2027 net sales: $285 million to $295 million
- Full year fiscal 2027 gross margin: 25.0% to 26.0% of sales
- Full year fiscal 2027 SG&A expense (including amortization): 17.5% to 18.5% of sales
- Full year fiscal 2027 Adjusted EBITDA: $35 million to $40 million
- Full year fiscal 2027 effective tax rate: 18% to 20%
- Full year fiscal 2027 capital expenditures: $15.0 million to $20.0 million
Price and volatility reaction
The stock moved +3.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.9 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 69.52 | 2026-11-04 |
| Close after release | 72.1 | 2026-11-05 |
| Realised move | +3.7% | close to close |
| 30d ATM IV change | -7.9 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
